Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Double Blinded, Randomized, Controlled, Non-inferiority Trial to Evaluate the Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Subjects Aged 65 Years and Above

NCT04548518 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT04548518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04548518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Double Blinded, Randomized, Controlled, Non-inferiority Trial to Evaluate the Immunogenicity and Safety of Tri Fluvac, a Seasonal Trivalent Inactivated Split Virion Influenza Vaccine, in Healthy Thai Subjects Aged 65 Years and Above
Lead sponsor
Mahidol University
Phase
Phase 3
Overall status
Unknown status
Start date
August 3, 2020
Completion date
December 31, 2023
Enrollment
816 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza